{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:34:31Z","timestamp":1791340471708,"version":"4.3.1"},"reference-count":55,"publisher":"Impact Journals, LLC","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2012,10,31]]},"DOI":"10.18632\/oncotarget.675","type":"journal-article","created":{"date-parts":[[2015,9,16]],"date-time":"2015-09-16T21:48:50Z","timestamp":1442440130000},"page":"1246-1258","source":"Crossref","is-referenced-by-count":133,"title":["DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma"],"prefix":"10.18632","volume":"3","author":[{"given":"Nicola","family":"Amodio","sequence":"first","affiliation":[{"name":"Department of Experimental and Clinical Medicine, Magna Graecia University and Medical Oncology Unit, T. Campanella Cancer Center, Salvatore Venuta University Campus, Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Leotta","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, Magna Graecia University and Medical Oncology Unit, T. Campanella Cancer Center, Salvatore Venuta University Campus, Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Bellizzi","sequence":"additional","affiliation":[{"name":"Department of Cell Biology, University of Calabria, Cosenza"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Di Martino","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, Magna Graecia University and Medical Oncology Unit, T. Campanella Cancer Center, Salvatore Venuta University Campus, Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"D\u2019Aquila","sequence":"additional","affiliation":[{"name":"Department of Cell Biology, University of Calabria, Cosenza"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Lionetti","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences University of Milan, Hematology 1, IRCCS Policlinico Foundation, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Fabiani","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, Magna Graecia University and Medical Oncology Unit, T. Campanella Cancer Center, Salvatore Venuta University Campus, Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Leone","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, Magna Graecia University and Medical Oncology Unit, T. Campanella Cancer Center, Salvatore Venuta University Campus, Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Gull\u00e0","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, Magna Graecia University and Medical Oncology Unit, T. Campanella Cancer Center, Salvatore Venuta University Campus, Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Passarino","sequence":"additional","affiliation":[{"name":"Department of Cell Biology, University of Calabria, Cosenza"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Caraglia","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Biophysics, Second University of Naples, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Negrini","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine and Diagnostics, University of Ferrara"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Neri","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences University of Milan, Hematology 1, IRCCS Policlinico Foundation, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Giordano","sequence":"additional","affiliation":[{"name":"Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierosandro","family":"Tagliaferri","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, Magna Graecia University and Medical Oncology Unit, T. Campanella Cancer Center, Salvatore Venuta University Campus, Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierfrancesco","family":"Tassone","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, Magna Graecia University and Medical Oncology Unit, T. Campanella Cancer Center, Salvatore Venuta University Campus, Catanzaro, Italy"},{"name":"Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2012,10,21]]},"reference":[{"issue":"4","key":"1","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.beha.2007.08.004","article-title":"Genetic events in the pathogenesis of multiple myeloma","volume":"20","author":"Kuehl","year":"2007","journal-title":"Best Pract Res Clin Haematol"},{"issue":"5","key":"2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrc3257","article-title":"The genetic architecture of multiple myeloma","volume":"12","author":"Davies","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"3","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1146\/annurev-pathol-011110-130249","article-title":"Pathogenesis of myeloma","volume":"6","author":"Carrasco","year":"2011","journal-title":"Annual review of pathology"},{"issue":"12","key":"4","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1038\/leu.2009.174","article-title":"International Myeloma Working Group molecular classification of multiple myeloma: spotlight review","volume":"23","author":"Chen-Kiang","year":"2009","journal-title":"Leukemia"},{"issue":"7","key":"5","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2174\/156800912802429300","article-title":"Molecular targets for the treatment of multiple myeloma","volume":"12","author":"Caraglia","year":"2012","journal-title":"Curr Cancer Drug Targets"},{"issue":"7","key":"6","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2174\/156800912802429373","article-title":"Targeted therapy of multiple myeloma: the changing paradigm at the beginning of the new millennium","volume":"12","author":"Gentile","year":"2012","journal-title":"Curr Cancer Drug Targets"},{"issue":"1","key":"7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.18632\/oncotarget.109","article-title":"A critical role for the NFkB pathway in multiple myeloma","volume":"1","author":"Kuehl","year":"2010","journal-title":"Oncotarget"},{"issue":"10","key":"8","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1038\/sj.leu.2403434","article-title":"DNA methylation changes in multiple myeloma","volume":"18","author":"Osieka","year":"2004","journal-title":"Leukemia"},{"issue":"1","key":"9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.blre.2005.01.006","article-title":"The fundamental role of epigenetics in hematopoietic malignancies","volume":"20","author":"Baylin","year":"2006","journal-title":"Blood Rev"},{"issue":"8","key":"10","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1007\/s00018-003-3088-6","article-title":"Structure, function and evolution of CpG island promoters","volume":"60","author":"Antequera","year":"2003","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"11","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrg816","article-title":"The fundamental role of epigenetic events in cancer","volume":"3","author":"Baylin","year":"2002","journal-title":"Nat Rev Genet"},{"issue":"24","key":"12","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1038\/sj.onc.1204341","article-title":"DNA methylation, methyltransferases, and cancer","volume":"20","author":"Robertson","year":"2001","journal-title":"Oncogene"},{"issue":"16","key":"13","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1093\/hmg\/9.16.2395","article-title":"The DNA methyltransferases of mammals","volume":"9","author":"Bestor","year":"2000","journal-title":"Hum Mol Genet"},{"issue":"11","key":"14","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1093\/nar\/27.11.2291","article-title":"The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors","volume":"27","author":"Jones","year":"1999","journal-title":"Nucleic Acids Res"},{"issue":"5400","key":"15","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1126\/science.283.5400.387","article-title":"Role of DNA 5-methylcytosine transferase in cell transformation by fos","volume":"283","author":"Curran","year":"1999","journal-title":"Science"},{"issue":"15","key":"16","doi-asserted-by":"crossref","first-page":"10105","DOI":"10.1074\/jbc.274.15.10105","article-title":"DNA methyltransferase is a downstream effector of cellular transformation triggered by simian virus 40 large T antigen","volume":"274","author":"Szyf","year":"1999","journal-title":"J Biol Chem"},{"issue":"10","key":"17","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1093\/nar\/28.10.2108","article-title":"Differential mRNA expression of the human DNA methyltransferases (DNMTs) 1, 3a and 3b during the G(0)\/G(1) to S phase transition in normal and tumor cells","volume":"28","author":"Jones","year":"2000","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"18","doi-asserted-by":"crossref","first-page":"850","DOI":"10.18632\/oncotarget.347","article-title":"Do AML patients with DNMT3A exon 23 mutations benefit from idarubicin as compared to daunorubicin? A single center experience","volume":"2","author":"Huynh","year":"2011","journal-title":"Oncotarget"},{"issue":"18","key":"19","doi-asserted-by":"crossref","first-page":"18302","DOI":"10.1074\/jbc.M501675200","article-title":"Increased protein stability causes DNA methyltransferase 1 dysregulation in breast cancer","volume":"280","author":"Nelson","year":"2005","journal-title":"J Biol Chem"},{"issue":"9","key":"20","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1158\/0008-5472.CAN-04-2158","article-title":"Regulation of DNA methyltransferase 1 by the pRb\/E2F1 pathway","volume":"65","author":"Day","year":"2005","journal-title":"Cancer Res"},{"issue":"9","key":"21","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1182\/blood.V97.9.2823","article-title":"Methylation profiling in acute myeloid leukemia","volume":"97","author":"Issa","year":"2001","journal-title":"Blood"},{"issue":"4","key":"22","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0168-9525(99)01971-X","article-title":"DNA hypermethylation in tumorigenesis: epigenetics joins genetics","volume":"16","author":"Herman","year":"2000","journal-title":"Trends Genet"},{"issue":"6","key":"23","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ccr.2006.04.020","article-title":"Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells","volume":"9","author":"Jones","year":"2006","journal-title":"Cancer Cell"},{"issue":"40","key":"24","doi-asserted-by":"crossref","first-page":"15805","DOI":"10.1073\/pnas.0707628104","article-title":"MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B","volume":"104","author":"Calin","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"25","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"issue":"7","key":"26","doi-asserted-by":"crossref","first-page":"838","DOI":"10.2174\/156800912802429355","article-title":"Promises and Challenges of MicroRNA-based Treatment of Multiple Myeloma","volume":"12","author":"Tassone","year":"2012","journal-title":"Curr Cancer Drug Targets"},{"key":"27","article-title":"Synthetic miR-34a mimics as a novel therapeutic agent for Multiple Myeloma: in vitro and in vivo evidence","author":"Shammas","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"6","key":"28","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/mt.2011.48","article-title":"Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice","volume":"19","author":"Slack","year":"2011","journal-title":"Mol Ther"},{"issue":"4","key":"29","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/leu.2010.300","article-title":"A unique three-dimensional SCID-polymeric scaffold (SCID-synth-hu) model for in vivo expansion of human primary multiple myeloma cells","volume":"25","author":"Tassone","year":"2011","journal-title":"Leukemia"},{"issue":"7","key":"30","doi-asserted-by":"crossref","first-page":"814","DOI":"10.2174\/156800912802429292","article-title":"Mouse models as a translational platform for the development of new therapeutic agents in multiple myeloma","volume":"12","author":"Tagliaferri","year":"2012","journal-title":"Curr Cancer Drug Targets"},{"issue":"5","key":"31","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ng1536","article-title":"Combinatorial microRNA target predictions","volume":"37","author":"Rajewsky","year":"2005","journal-title":"Nat Genet"},{"issue":"7","key":"32","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0092-8674(03)01018-3","article-title":"Prediction of mammalian microRNA targets","volume":"115","author":"Burge","year":"2003","journal-title":"Cell"},{"issue":"1","key":"33","first-page":"169","article-title":"Global DNA methylation in old subjects is correlated with frailty","volume":"34","author":"Passarino","journal-title":"Age (Dordr)"},{"issue":"12","key":"34","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1093\/carcin\/bgm206","article-title":"Alterations of DNA methylation associated with abnormalities of DNA methyltransferases in human cancers during transition from a precancerous to a malignant state","volume":"28","author":"Hirohashi","year":"2007","journal-title":"Carcinogenesis"},{"issue":"5","key":"35","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1182\/blood.V97.5.1172","article-title":"Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia","volume":"97","author":"Sasaki","year":"2001","journal-title":"Blood"},{"issue":"16","key":"36","first-page":"3855","article-title":"Abnormal regulation of DNA methyltransferase expression during colorectal carcinogenesis","volume":"59","author":"Nelson","year":"1999","journal-title":"Cancer Res"},{"issue":"5","key":"37","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1309\/AJCPHGQ69FXDFWII","article-title":"Overexpression of DNA methyltransferases 1, 3a, and 3b significantly correlates with retinoblastoma tumorigenesis","volume":"134","author":"Wei","year":"2010","journal-title":"Am J Clin Pathol"},{"issue":"25","key":"38","doi-asserted-by":"crossref","first-page":"6411","DOI":"10.1182\/blood-2008-07-170589","article-title":"MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1","volume":"113","author":"Andreeff","year":"2009","journal-title":"Blood"},{"issue":"7","key":"39","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1182\/blood-2002-06-1735","article-title":"SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma","volume":"101","author":"Herman","year":"2003","journal-title":"Blood"},{"issue":"4","key":"40","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1046\/j.1365-2141.2002.03749.x","article-title":"Methylation is an inactivating mechanism of the p16 gene in multiple myeloma associated with high plasma cell proliferation and short survival","volume":"118","author":"San Miguel","year":"2002","journal-title":"Br J Haematol"},{"issue":"11","key":"41","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1158\/0008-5472.CAN-04-3589","article-title":"Interleukin 6 supports the maintenance of p53 tumor suppressor gene promoter methylation","volume":"65","author":"Farrar","year":"2005","journal-title":"Cancer Res"},{"issue":"7","key":"42","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1182\/blood.V89.7.2500","article-title":"Frequent hypermethylation of p16 and p15 genes in multiple myeloma","volume":"89","author":"Huang","year":"1997","journal-title":"Blood"},{"issue":"3","key":"43","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3816\/CLM.2009.n.047","article-title":"Von Hippel-Lindau methylation status in patients with multiple myeloma: a potential predictive factor for the development of bone disease","volume":"9","author":"Bourantas","year":"2009","journal-title":"Clin Lymphoma Myeloma"},{"issue":"15","key":"44","doi-asserted-by":"crossref","first-page":"5874","DOI":"10.1073\/pnas.0801130105","article-title":"MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins","volume":"105","author":"Ahlquist","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"26","key":"45","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1182\/blood-2009-03-211938","article-title":"MicroRNA 29b functions in acute myeloid leukemia","volume":"114","author":"Croce","year":"2009","journal-title":"Blood"},{"issue":"3","key":"46","doi-asserted-by":"crossref","first-page":"224","DOI":"10.18632\/oncotarget.129","article-title":"Is miR-29 an oncogene or tumor suppressor in CLL?","volume":"1","author":"Croce","year":"2010","journal-title":"Oncotarget"},{"issue":"6","key":"47","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1158\/1535-7163.MCT-07-0010","article-title":"5-Azacytidine, a DNA methyltransferase inhibitor, induces ATR-mediated DNA double-strand break responses, apoptosis, and synergistic cytotoxicity with doxorubicin and bortezomib against multiple myeloma cells","volume":"6","author":"Anderson","year":"2007","journal-title":"Mol Cancer Ther"},{"issue":"23","key":"48","doi-asserted-by":"crossref","first-page":"7144","DOI":"10.1158\/1078-0432.CCR-09-1483","article-title":"A high-affinity fully human anti-IL-6 mAb, 1339, for the treatment of multiple myeloma","volume":"15","author":"Munshi","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"1","key":"49","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/sj.thj.6200075","article-title":"Gp130 and ras mediated signaling in human plasma cell line INA-6: a cytokine-regulated tumor model for plasmacytoma","volume":"2","author":"Gramatzki","year":"2001","journal-title":"The hematology journal : the official journal of the European Haematology Association \/ EHA"},{"key":"50","article-title":"Canonical and non canonical Hedgehog pathway in the pathogenesis of multiple myeloma","author":"Anderson","year":"2012","journal-title":"Blood"},{"issue":"5","key":"51","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.2353\/ajpath.2010.091075","article-title":"Oncogenic role of the E3 ubiquitin ligase NEDD4-1, a PTEN negative regulator, in non-small-cell lung carcinomas","volume":"177","author":"Viglietto","year":"2010","journal-title":"Am J Pathol"},{"issue":"4","key":"52","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Schmittgen","year":"2001","journal-title":"Methods"},{"issue":"4","key":"53","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1365-2141.2008.07387.x","article-title":"In vivo anti-myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitor","volume":"143","author":"Tassone","year":"2008","journal-title":"Br J Haematol"},{"issue":"7","key":"54","doi-asserted-by":"crossref","first-page":"648","DOI":"10.4161\/cbt.8.7.7968","article-title":"Loss of BRCA1 function increases the antitumor activity of cisplatin against human breast cancer xenografts in vivo","volume":"8","author":"Tagliaferri","year":"2009","journal-title":"Cancer biology & therapy"},{"issue":"1","key":"55","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2141.2006.06122.x","article-title":"In vivo and in vitro cytotoxicity of R-etodolac with dexamethasone in glucocorticoid-resistant multiple myeloma cells","volume":"134","author":"Anderson","year":"2006","journal-title":"Br J Haematol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.675","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T05:25:29Z","timestamp":1718083529000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,21]]},"references-count":55,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["675","23100393"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.675","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,21]]}}}